Equity
€111,976 ▼ 9.9%
FEM-Cor paid out €42,818 in dividends. That is 141% of the 2025 profit.
FEM-Cor
Lifetime
4 annual accounts with figures on one time axispeak €80,195 (2022)
€57,598▲ 63.0%
peak €42,369 (2022)
€30,469▲ 165%
peak €124,324 (2024)
€111,976▼ 9.9%
€67,850▲ 417%
Board2 names since 2021
1 director
Documentsfilings and deeds
23-12-202539 days before the deadline
2025micro format
Gross margin from €35,341 to €57,598Result from €11,506 to €30,469Dividend €42,818Debts from €13,129 to €67,850Investments €82,809
Key points
from the 2025 annual accountsTurnover
≈ €130,000 estimated
The micro format states no turnover.
Debts
€67,850 ▲ 417%
Debts rose by €54,721 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Investments
€85,457 6.3 × depreciation
Green is investment, beige is depreciation.
Liquidity
2.11 was 7.75 in 2024
Short-term debts rose from €13,129 to €35,555.
Filings
4 annual accounts since 2022
The last four annual accounts were filed 0 to 39 days before the end of the period.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 26,973 companies had the same profile as FEM-Cor has now. Each dot stands for 68 companies, two years later.
94.8%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,973 companies, not a prediction for FEM-Cor. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0761700715
Incorporation
Founding capital of €40,000, 200 shares · Founder: · Appointments: (company auditor) and (director) · published on 20-01-2021 · Gazette deed
First establishment
Meidoornlaan 5, Meise
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| FEM-Cor Meise | €179,826 | €57,598 | 62.3% | - |
| SOCHA Oupeye | €171,755 | €55,821 | 81.1% | - |
| Centre de Médecine Intégrative Assesse | €162,927 | €58,569 | 4.4% | - |
| Dr. Arzu TEK Awans | €190,646 | €55,539 | 83.5% | - |
| DR SABATIELLO Fexhe-le-Haut-Clocher | €187,977 | €55,695 | 90.7% | - |
| Docteur A. Paun - Chirurgie Plastique & Esthétique Uccle | €171,788 | €62,585 | 75.8% | - |
| DOCTEUR BONTE AMANDINE Tournai | €184,154 | €54,411 | 50.6% | - |
These companies have the same main activity as FEM-Cor: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €163,000 and €191,000, founded between 2019 and 2021.
Official details
Source: KBO- Status
- Active since 18-01-2021Normal situation
- Activity
- Specialist medical practiceNACE 86220and 1 other
- Establishment unit
- 2.312.989.6451860 Meise, since 18-01-2021
- Financial year end
- 30 June
- Peppol
- Reachable since 27-11-2024
Annual accounts to 30-06-2025
- €179,826▲ 30.8%
- Filing
- Filed on 23-12-2025, 39 days before the end of the filing period
Insights on FEM-Cor
FEM-Cor files the micro format. That format states no turnover. The gross margin fell from €80,195 in 2022 to €57,598 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about FEM-Cor
- What is the company number of FEM-Cor?
- The company number of FEM-Cor is 0761.700.715. The VAT number is the same number with BE in front: BE 0761.700.715.
- Where is FEM-Cor based?
- The registered office is at Meidoornlaan 5, 1860 Meise.Company details
- What does FEM-Cor do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of FEM-Cor?
- FEM-Cor is a private limited company (BV).
- When was FEM-Cor founded?
- FEM-Cor was founded on 18-01-2021.
- Is FEM-Cor still active?
- Yes, FEM-Cor is an active enterprise in the KBO register.
- What is the turnover of FEM-Cor?
- The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €57,598 and 32 comparable companies (NACE 862). It probably lies between €100,000 and €170,000.Financials
- Is FEM-Cor profitable?
- In financial year 2025, FEM-Cor made a profit of €30,469.
- Where can I find the annual accounts of FEM-Cor?
- FEM-Cor filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of FEM-Cor due?
- FEM-Cor must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.